This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Roche
Roche, officially known as F. Hoffmann-La Roche Ltd, is a global leader in the pharmaceutical and diagnostics industries, headquartered in Basel, Switzerland. Established in 1896, Roche has consistently driven innovation in healthcare, focusing on areas such as oncology, immunology, infectious diseases, and personalised medicine. With a strong presence in Europe, North America, and Asia, Roche is renowned for its pioneering products, including targeted therapies and advanced diagnostic tools. The company’s commitment to research and development has positioned it as a market leader, with notable achievements such as the introduction of groundbreaking cancer treatments and diagnostic solutions that enhance patient care. Roche's unique integration of pharmaceuticals and diagnostics sets it apart, ensuring comprehensive healthcare solutions that address complex medical needs.
DitchCarbon Score
How does Roche's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche's score of 6 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche's reported carbon emissions
Roche, headquartered in France, currently does not provide specific carbon emissions data for the most recent year, as indicated by the absence of reported figures. The company is a current subsidiary of Roche, and while it inherits data from its parent organization, no specific emissions figures or reduction targets have been disclosed. Roche has not outlined any specific reduction initiatives or commitments, such as Science-Based Targets (SBTi) or other climate pledges. This lack of publicly available data suggests that Roche may still be in the process of developing or formalising its climate strategy. As a significant player in the pharmaceutical industry, Roche's climate commitments and emissions management will be crucial in addressing the broader environmental impacts associated with healthcare. The company’s future initiatives will likely align with industry standards and expectations for sustainability and carbon reduction.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Roche is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
